Sponsor:
Erin Rowell
Code:
NCT06692049
Conditions
DSD, 46,XY
DSD, Ovotesticular
DSD, Sex Chromosome
Disorders of Sex Development
Disorder of Sex Development, 46,XY
Eligibility Criteria
Sex: All
Age: 0 - 30
Healthy Volunteers: Accepted
Interventions
Gonadectomy
Brief summary:
Conditions
DSD, 46,XY
DSD, Ovotesticular
DSD, Sex Chromosome
Disorders of Sex Development
Disorder of Sex Development, 46,XY
Study ID
NCT06692049
Start date
Apr 4, 2018
Status verified date
Jul, 2026
Completion date
Dec 31, 2035
Anticipated
Primary completion date
Dec 31, 2030
Anticipated
Eligibility Criteria
Sex: All
Age: 0 - 30
Healthy Volunteers: Accepted
Enrollment
250 participants
Anticipated
Arms
Disorders of Sex Development (DSD)
Interventions
Gonadectomy
Primary outcome measure
Central contacts
Locations
Ann & Robert H. Lurie Children's Hospital of Chicago
Recruiting
Chicago, Illinois, United States, 60611
Contacts
Principal Investigator:
Erin Rowell, MD
Sponsor
Erin Rowell
Last update posted
Sep 3, 2026
Last verified
Jul, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Erin Rowell on 2026-09-03.